Global Meropenem for Injection Market Growth 2026-2032
The global Meropenem for Injection market size is predicted to grow from US$ 1804 million in 2025 to US$ 2443 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032.
Meropenem for Injection is one of the most widely used broad-spectrum carbapenem antibiotic formulations, primarily indicated for severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it plays a central role in ICUs and critical care departments. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging materials, as well as high-standard aseptic manufacturing lines and testing equipment, all of which require stringent process scale-up, impurity control, and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem for injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Constrained by technical barriers in sterile manufacturing, intensive quality system investments, and persistent pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 40%–55%, reflecting a market characterized by stable demand, intense competition, and scalable yet sustainable profitability.
United States market for Meropenem for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Meropenem for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Meropenem for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Meropenem for Injection players cover Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Meropenem for Injection Industry Forecast” looks at past sales and reviews total world Meropenem for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Meropenem for Injection sales for 2026 through 2032. With Meropenem for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meropenem for Injection industry.
This Insight Report provides a comprehensive analysis of the global Meropenem for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meropenem for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meropenem for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meropenem for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meropenem for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Meropenem for Injection market?
What factors are driving Meropenem for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meropenem for Injection market opportunities vary by end market size?
How does Meropenem for Injection break out by Type, by Application?
Meropenem for Injection is one of the most widely used broad-spectrum carbapenem antibiotic formulations, primarily indicated for severe pneumonia, sepsis, complicated intra-abdominal infections, central nervous system infections, and other serious hospital-acquired infections caused by resistant Gram-negative pathogens, and it plays a central role in ICUs and critical care departments. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging materials, as well as high-standard aseptic manufacturing lines and testing equipment, all of which require stringent process scale-up, impurity control, and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and specialty hospitals, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of meropenem for injection in 2025 is estimated at approximately 380 million vials, with actual sales volume of around 318 million vials and an average global ex-factory price of about USD 5.8 per vial. Constrained by technical barriers in sterile manufacturing, intensive quality system investments, and persistent pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 40%–55%, reflecting a market characterized by stable demand, intense competition, and scalable yet sustainable profitability.
United States market for Meropenem for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Meropenem for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Meropenem for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Meropenem for Injection players cover Sumitomo Pharma, Pfizer, Fresenius, Emcure Pharmaceuticals, Aurobindo Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Meropenem for Injection Industry Forecast” looks at past sales and reviews total world Meropenem for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Meropenem for Injection sales for 2026 through 2032. With Meropenem for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meropenem for Injection industry.
This Insight Report provides a comprehensive analysis of the global Meropenem for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meropenem for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meropenem for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meropenem for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meropenem for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.25 g (Calculated as C??H??N?O?S)
- 0.5 g (Calculated as C??H??N?O?S)
- 1.0 g (Calculated as C??H??N?O?S)
- Severe Hospital-acquired Infections
- Drug-resistant Gram-negative Infections
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sumitomo Pharma
- Pfizer
- Fresenius
- Emcure Pharmaceuticals
- Aurobindo Pharma
- Sun Pharmaceutical
- Hikma Pharmaceuticals
- CSPC Pharmaceutical Group
- Shenzhen Haibin Pharmaceutical
What is the 10-year outlook for the global Meropenem for Injection market?
What factors are driving Meropenem for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meropenem for Injection market opportunities vary by end market size?
How does Meropenem for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meropenem for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Meropenem for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Meropenem for Injection by Country/Region, 2021, 2025 & 2032
2.2 Meropenem for Injection Segment by Type
2.2.1 0.25 g (Calculated as C??H??N?O?S)
2.2.2 0.5 g (Calculated as C??H??N?O?S)
2.2.3 1.0 g (Calculated as C??H??N?O?S)
2.2.4 Meropenem for Injection Sales by Type
2.2.4.1 Global Meropenem for Injection Sales Market Share by Type (2021-2026)
2.2.4.2 Global Meropenem for Injection Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Meropenem for Injection Sale Price by Type (2021-2026)
2.3 Meropenem for Injection Segment by Clinical Indication
2.3.1 Severe Hospital-acquired Infections
2.3.2 Drug-resistant Gram-negative Infections
2.3.3 Others
2.3.4 Meropenem for Injection Sales by Clinical Indication
2.3.4.1 Global Meropenem for Injection Sales Market Share by Clinical Indication (2021-2026)
2.3.4.2 Global Meropenem for Injection Revenue and Market Share by Clinical Indication (2021-2026)
2.3.4.3 Global Meropenem for Injection Sale Price by Clinical Indication (2021-2026)
2.4 Meropenem for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.4.4 Meropenem for Injection Sales by Application
2.4.4.1 Global Meropenem for Injection Sale Market Share by Application (2021-2026)
2.4.4.2 Global Meropenem for Injection Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Meropenem for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Meropenem for Injection Breakdown Data by Company
3.1.1 Global Meropenem for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Meropenem for Injection Sales Market Share by Company (2021-2026)
3.2 Global Meropenem for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Meropenem for Injection Revenue by Company (2021-2026)
3.2.2 Global Meropenem for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Meropenem for Injection Sale Price by Company
3.4 Key Manufacturers Meropenem for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meropenem for Injection Product Location Distribution
3.4.2 Players Meropenem for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEROPENEM FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Meropenem for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Meropenem for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Meropenem for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Meropenem for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Meropenem for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Meropenem for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Meropenem for Injection Sales Growth
4.4 APAC Meropenem for Injection Sales Growth
4.5 Europe Meropenem for Injection Sales Growth
4.6 Middle East & Africa Meropenem for Injection Sales Growth
5 AMERICAS
5.1 Americas Meropenem for Injection Sales by Country
5.1.1 Americas Meropenem for Injection Sales by Country (2021-2026)
5.1.2 Americas Meropenem for Injection Revenue by Country (2021-2026)
5.2 Americas Meropenem for Injection Sales by Type (2021-2026)
5.3 Americas Meropenem for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meropenem for Injection Sales by Region
6.1.1 APAC Meropenem for Injection Sales by Region (2021-2026)
6.1.2 APAC Meropenem for Injection Revenue by Region (2021-2026)
6.2 APAC Meropenem for Injection Sales by Type (2021-2026)
6.3 APAC Meropenem for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meropenem for Injection by Country
7.1.1 Europe Meropenem for Injection Sales by Country (2021-2026)
7.1.2 Europe Meropenem for Injection Revenue by Country (2021-2026)
7.2 Europe Meropenem for Injection Sales by Type (2021-2026)
7.3 Europe Meropenem for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meropenem for Injection by Country
8.1.1 Middle East & Africa Meropenem for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Meropenem for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Meropenem for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Meropenem for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meropenem for Injection
10.3 Manufacturing Process Analysis of Meropenem for Injection
10.4 Industry Chain Structure of Meropenem for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meropenem for Injection Distributors
11.3 Meropenem for Injection Customer
12 WORLD FORECAST REVIEW FOR MEROPENEM FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Meropenem for Injection Market Size Forecast by Region
12.1.1 Global Meropenem for Injection Forecast by Region (2027-2032)
12.1.2 Global Meropenem for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Meropenem for Injection Forecast by Type (2027-2032)
12.7 Global Meropenem for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sumitomo Pharma
13.1.1 Sumitomo Pharma Company Information
13.1.2 Sumitomo Pharma Meropenem for Injection Product Portfolios and Specifications
13.1.3 Sumitomo Pharma Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sumitomo Pharma Main Business Overview
13.1.5 Sumitomo Pharma Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Meropenem for Injection Product Portfolios and Specifications
13.2.3 Pfizer Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Fresenius
13.3.1 Fresenius Company Information
13.3.2 Fresenius Meropenem for Injection Product Portfolios and Specifications
13.3.3 Fresenius Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Main Business Overview
13.3.5 Fresenius Latest Developments
13.4 Emcure Pharmaceuticals
13.4.1 Emcure Pharmaceuticals Company Information
13.4.2 Emcure Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
13.4.3 Emcure Pharmaceuticals Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Emcure Pharmaceuticals Main Business Overview
13.4.5 Emcure Pharmaceuticals Latest Developments
13.5 Aurobindo Pharma
13.5.1 Aurobindo Pharma Company Information
13.5.2 Aurobindo Pharma Meropenem for Injection Product Portfolios and Specifications
13.5.3 Aurobindo Pharma Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Aurobindo Pharma Main Business Overview
13.5.5 Aurobindo Pharma Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Hikma Pharmaceuticals
13.7.1 Hikma Pharmaceuticals Company Information
13.7.2 Hikma Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hikma Pharmaceuticals Main Business Overview
13.7.5 Hikma Pharmaceuticals Latest Developments
13.8 CSPC Pharmaceutical Group
13.8.1 CSPC Pharmaceutical Group Company Information
13.8.2 CSPC Pharmaceutical Group Meropenem for Injection Product Portfolios and Specifications
13.8.3 CSPC Pharmaceutical Group Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CSPC Pharmaceutical Group Main Business Overview
13.8.5 CSPC Pharmaceutical Group Latest Developments
13.9 Shenzhen Haibin Pharmaceutical
13.9.1 Shenzhen Haibin Pharmaceutical Company Information
13.9.2 Shenzhen Haibin Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
13.9.3 Shenzhen Haibin Pharmaceutical Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shenzhen Haibin Pharmaceutical Main Business Overview
13.9.5 Shenzhen Haibin Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meropenem for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Meropenem for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Meropenem for Injection by Country/Region, 2021, 2025 & 2032
2.2 Meropenem for Injection Segment by Type
2.2.1 0.25 g (Calculated as C??H??N?O?S)
2.2.2 0.5 g (Calculated as C??H??N?O?S)
2.2.3 1.0 g (Calculated as C??H??N?O?S)
2.2.4 Meropenem for Injection Sales by Type
2.2.4.1 Global Meropenem for Injection Sales Market Share by Type (2021-2026)
2.2.4.2 Global Meropenem for Injection Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Meropenem for Injection Sale Price by Type (2021-2026)
2.3 Meropenem for Injection Segment by Clinical Indication
2.3.1 Severe Hospital-acquired Infections
2.3.2 Drug-resistant Gram-negative Infections
2.3.3 Others
2.3.4 Meropenem for Injection Sales by Clinical Indication
2.3.4.1 Global Meropenem for Injection Sales Market Share by Clinical Indication (2021-2026)
2.3.4.2 Global Meropenem for Injection Revenue and Market Share by Clinical Indication (2021-2026)
2.3.4.3 Global Meropenem for Injection Sale Price by Clinical Indication (2021-2026)
2.4 Meropenem for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.4.4 Meropenem for Injection Sales by Application
2.4.4.1 Global Meropenem for Injection Sale Market Share by Application (2021-2026)
2.4.4.2 Global Meropenem for Injection Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Meropenem for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Meropenem for Injection Breakdown Data by Company
3.1.1 Global Meropenem for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Meropenem for Injection Sales Market Share by Company (2021-2026)
3.2 Global Meropenem for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Meropenem for Injection Revenue by Company (2021-2026)
3.2.2 Global Meropenem for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Meropenem for Injection Sale Price by Company
3.4 Key Manufacturers Meropenem for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meropenem for Injection Product Location Distribution
3.4.2 Players Meropenem for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEROPENEM FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Meropenem for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Meropenem for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Meropenem for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Meropenem for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Meropenem for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Meropenem for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Meropenem for Injection Sales Growth
4.4 APAC Meropenem for Injection Sales Growth
4.5 Europe Meropenem for Injection Sales Growth
4.6 Middle East & Africa Meropenem for Injection Sales Growth
5 AMERICAS
5.1 Americas Meropenem for Injection Sales by Country
5.1.1 Americas Meropenem for Injection Sales by Country (2021-2026)
5.1.2 Americas Meropenem for Injection Revenue by Country (2021-2026)
5.2 Americas Meropenem for Injection Sales by Type (2021-2026)
5.3 Americas Meropenem for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meropenem for Injection Sales by Region
6.1.1 APAC Meropenem for Injection Sales by Region (2021-2026)
6.1.2 APAC Meropenem for Injection Revenue by Region (2021-2026)
6.2 APAC Meropenem for Injection Sales by Type (2021-2026)
6.3 APAC Meropenem for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meropenem for Injection by Country
7.1.1 Europe Meropenem for Injection Sales by Country (2021-2026)
7.1.2 Europe Meropenem for Injection Revenue by Country (2021-2026)
7.2 Europe Meropenem for Injection Sales by Type (2021-2026)
7.3 Europe Meropenem for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meropenem for Injection by Country
8.1.1 Middle East & Africa Meropenem for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Meropenem for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Meropenem for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Meropenem for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meropenem for Injection
10.3 Manufacturing Process Analysis of Meropenem for Injection
10.4 Industry Chain Structure of Meropenem for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meropenem for Injection Distributors
11.3 Meropenem for Injection Customer
12 WORLD FORECAST REVIEW FOR MEROPENEM FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Meropenem for Injection Market Size Forecast by Region
12.1.1 Global Meropenem for Injection Forecast by Region (2027-2032)
12.1.2 Global Meropenem for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Meropenem for Injection Forecast by Type (2027-2032)
12.7 Global Meropenem for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sumitomo Pharma
13.1.1 Sumitomo Pharma Company Information
13.1.2 Sumitomo Pharma Meropenem for Injection Product Portfolios and Specifications
13.1.3 Sumitomo Pharma Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sumitomo Pharma Main Business Overview
13.1.5 Sumitomo Pharma Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Meropenem for Injection Product Portfolios and Specifications
13.2.3 Pfizer Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Fresenius
13.3.1 Fresenius Company Information
13.3.2 Fresenius Meropenem for Injection Product Portfolios and Specifications
13.3.3 Fresenius Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Fresenius Main Business Overview
13.3.5 Fresenius Latest Developments
13.4 Emcure Pharmaceuticals
13.4.1 Emcure Pharmaceuticals Company Information
13.4.2 Emcure Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
13.4.3 Emcure Pharmaceuticals Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Emcure Pharmaceuticals Main Business Overview
13.4.5 Emcure Pharmaceuticals Latest Developments
13.5 Aurobindo Pharma
13.5.1 Aurobindo Pharma Company Information
13.5.2 Aurobindo Pharma Meropenem for Injection Product Portfolios and Specifications
13.5.3 Aurobindo Pharma Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Aurobindo Pharma Main Business Overview
13.5.5 Aurobindo Pharma Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
13.6.3 Sun Pharmaceutical Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Hikma Pharmaceuticals
13.7.1 Hikma Pharmaceuticals Company Information
13.7.2 Hikma Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hikma Pharmaceuticals Main Business Overview
13.7.5 Hikma Pharmaceuticals Latest Developments
13.8 CSPC Pharmaceutical Group
13.8.1 CSPC Pharmaceutical Group Company Information
13.8.2 CSPC Pharmaceutical Group Meropenem for Injection Product Portfolios and Specifications
13.8.3 CSPC Pharmaceutical Group Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CSPC Pharmaceutical Group Main Business Overview
13.8.5 CSPC Pharmaceutical Group Latest Developments
13.9 Shenzhen Haibin Pharmaceutical
13.9.1 Shenzhen Haibin Pharmaceutical Company Information
13.9.2 Shenzhen Haibin Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
13.9.3 Shenzhen Haibin Pharmaceutical Meropenem for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shenzhen Haibin Pharmaceutical Main Business Overview
13.9.5 Shenzhen Haibin Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Meropenem for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Meropenem for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.25 g (Calculated as C??H??N?O?S)
Table 4. Major Players of 0.5 g (Calculated as C??H??N?O?S)
Table 5. Major Players of 1.0 g (Calculated as C??H??N?O?S)
Table 6. Global Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 7. Global Meropenem for Injection Sales Market Share by Type (2021-2026)
Table 8. Global Meropenem for Injection Revenue by Type (2021-2026) & ($ million)
Table 9. Global Meropenem for Injection Revenue Market Share by Type (2021-2026)
Table 10. Global Meropenem for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Severe Hospital-acquired Infections
Table 12. Major Players of Drug-resistant Gram-negative Infections
Table 13. Major Players of Others
Table 14. Global Meropenem for Injection Sales by Clinical Indication (2021-2026) & (K Units)
Table 15. Global Meropenem for Injection Sales Market Share by Clinical Indication (2021-2026)
Table 16. Global Meropenem for Injection Revenue by Clinical Indication (2021-2026) & ($ million)
Table 17. Global Meropenem for Injection Revenue Market Share by Clinical Indication (2021-2026)
Table 18. Global Meropenem for Injection Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 19. Global Meropenem for Injection Sale by Application (2021-2026) & (K Units)
Table 20. Global Meropenem for Injection Sale Market Share by Application (2021-2026)
Table 21. Global Meropenem for Injection Revenue by Application (2021-2026) & ($ million)
Table 22. Global Meropenem for Injection Revenue Market Share by Application (2021-2026)
Table 23. Global Meropenem for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Meropenem for Injection Sales by Company (2021-2026) & (K Units)
Table 25. Global Meropenem for Injection Sales Market Share by Company (2021-2026)
Table 26. Global Meropenem for Injection Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Meropenem for Injection Revenue Market Share by Company (2021-2026)
Table 28. Global Meropenem for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Meropenem for Injection Producing Area Distribution and Sales Area
Table 30. Players Meropenem for Injection Products Offered
Table 31. Meropenem for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Meropenem for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Meropenem for Injection Sales Market Share Geographic Region (2021-2026)
Table 36. Global Meropenem for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Meropenem for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Meropenem for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Meropenem for Injection Sales Market Share by Country/Region (2021-2026)
Table 40. Global Meropenem for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Meropenem for Injection Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Meropenem for Injection Sales by Country (2021-2026) & (K Units)
Table 43. Americas Meropenem for Injection Sales Market Share by Country (2021-2026)
Table 44. Americas Meropenem for Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 46. Americas Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 47. APAC Meropenem for Injection Sales by Region (2021-2026) & (K Units)
Table 48. APAC Meropenem for Injection Sales Market Share by Region (2021-2026)
Table 49. APAC Meropenem for Injection Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 51. APAC Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 52. Europe Meropenem for Injection Sales by Country (2021-2026) & (K Units)
Table 53. Europe Meropenem for Injection Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 55. Europe Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Meropenem for Injection Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Meropenem for Injection Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Meropenem for Injection
Table 61. Key Market Challenges & Risks of Meropenem for Injection
Table 62. Key Industry Trends of Meropenem for Injection
Table 63. Meropenem for Injection Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Meropenem for Injection Distributors List
Table 66. Meropenem for Injection Customer List
Table 67. Global Meropenem for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Meropenem for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Meropenem for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Meropenem for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Meropenem for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Meropenem for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Meropenem for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Meropenem for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Meropenem for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Meropenem for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Meropenem for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Meropenem for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Meropenem for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Meropenem for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Sumitomo Pharma Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Sumitomo Pharma Meropenem for Injection Product Portfolios and Specifications
Table 83. Sumitomo Pharma Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Sumitomo Pharma Main Business
Table 85. Sumitomo Pharma Latest Developments
Table 86. Pfizer Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Meropenem for Injection Product Portfolios and Specifications
Table 88. Pfizer Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Fresenius Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Fresenius Meropenem for Injection Product Portfolios and Specifications
Table 93. Fresenius Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Fresenius Main Business
Table 95. Fresenius Latest Developments
Table 96. Emcure Pharmaceuticals Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Emcure Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
Table 98. Emcure Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Emcure Pharmaceuticals Main Business
Table 100. Emcure Pharmaceuticals Latest Developments
Table 101. Aurobindo Pharma Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 102. Aurobindo Pharma Meropenem for Injection Product Portfolios and Specifications
Table 103. Aurobindo Pharma Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Aurobindo Pharma Main Business
Table 105. Aurobindo Pharma Latest Developments
Table 106. Sun Pharmaceutical Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 107. Sun Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
Table 108. Sun Pharmaceutical Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Sun Pharmaceutical Main Business
Table 110. Sun Pharmaceutical Latest Developments
Table 111. Hikma Pharmaceuticals Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 112. Hikma Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
Table 113. Hikma Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Hikma Pharmaceuticals Main Business
Table 115. Hikma Pharmaceuticals Latest Developments
Table 116. CSPC Pharmaceutical Group Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 117. CSPC Pharmaceutical Group Meropenem for Injection Product Portfolios and Specifications
Table 118. CSPC Pharmaceutical Group Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. CSPC Pharmaceutical Group Main Business
Table 120. CSPC Pharmaceutical Group Latest Developments
Table 121. Shenzhen Haibin Pharmaceutical Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 122. Shenzhen Haibin Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
Table 123. Shenzhen Haibin Pharmaceutical Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Shenzhen Haibin Pharmaceutical Main Business
Table 125. Shenzhen Haibin Pharmaceutical Latest Developments
Table 1. Meropenem for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Meropenem for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.25 g (Calculated as C??H??N?O?S)
Table 4. Major Players of 0.5 g (Calculated as C??H??N?O?S)
Table 5. Major Players of 1.0 g (Calculated as C??H??N?O?S)
Table 6. Global Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 7. Global Meropenem for Injection Sales Market Share by Type (2021-2026)
Table 8. Global Meropenem for Injection Revenue by Type (2021-2026) & ($ million)
Table 9. Global Meropenem for Injection Revenue Market Share by Type (2021-2026)
Table 10. Global Meropenem for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Severe Hospital-acquired Infections
Table 12. Major Players of Drug-resistant Gram-negative Infections
Table 13. Major Players of Others
Table 14. Global Meropenem for Injection Sales by Clinical Indication (2021-2026) & (K Units)
Table 15. Global Meropenem for Injection Sales Market Share by Clinical Indication (2021-2026)
Table 16. Global Meropenem for Injection Revenue by Clinical Indication (2021-2026) & ($ million)
Table 17. Global Meropenem for Injection Revenue Market Share by Clinical Indication (2021-2026)
Table 18. Global Meropenem for Injection Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 19. Global Meropenem for Injection Sale by Application (2021-2026) & (K Units)
Table 20. Global Meropenem for Injection Sale Market Share by Application (2021-2026)
Table 21. Global Meropenem for Injection Revenue by Application (2021-2026) & ($ million)
Table 22. Global Meropenem for Injection Revenue Market Share by Application (2021-2026)
Table 23. Global Meropenem for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Meropenem for Injection Sales by Company (2021-2026) & (K Units)
Table 25. Global Meropenem for Injection Sales Market Share by Company (2021-2026)
Table 26. Global Meropenem for Injection Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Meropenem for Injection Revenue Market Share by Company (2021-2026)
Table 28. Global Meropenem for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Meropenem for Injection Producing Area Distribution and Sales Area
Table 30. Players Meropenem for Injection Products Offered
Table 31. Meropenem for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Meropenem for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Meropenem for Injection Sales Market Share Geographic Region (2021-2026)
Table 36. Global Meropenem for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Meropenem for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Meropenem for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Meropenem for Injection Sales Market Share by Country/Region (2021-2026)
Table 40. Global Meropenem for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Meropenem for Injection Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Meropenem for Injection Sales by Country (2021-2026) & (K Units)
Table 43. Americas Meropenem for Injection Sales Market Share by Country (2021-2026)
Table 44. Americas Meropenem for Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 46. Americas Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 47. APAC Meropenem for Injection Sales by Region (2021-2026) & (K Units)
Table 48. APAC Meropenem for Injection Sales Market Share by Region (2021-2026)
Table 49. APAC Meropenem for Injection Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 51. APAC Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 52. Europe Meropenem for Injection Sales by Country (2021-2026) & (K Units)
Table 53. Europe Meropenem for Injection Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 55. Europe Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Meropenem for Injection Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Meropenem for Injection Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Meropenem for Injection Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Meropenem for Injection Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Meropenem for Injection
Table 61. Key Market Challenges & Risks of Meropenem for Injection
Table 62. Key Industry Trends of Meropenem for Injection
Table 63. Meropenem for Injection Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Meropenem for Injection Distributors List
Table 66. Meropenem for Injection Customer List
Table 67. Global Meropenem for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Meropenem for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Meropenem for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Meropenem for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Meropenem for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Meropenem for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Meropenem for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Meropenem for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Meropenem for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Meropenem for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Meropenem for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Meropenem for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Meropenem for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Meropenem for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Sumitomo Pharma Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 82. Sumitomo Pharma Meropenem for Injection Product Portfolios and Specifications
Table 83. Sumitomo Pharma Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Sumitomo Pharma Main Business
Table 85. Sumitomo Pharma Latest Developments
Table 86. Pfizer Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Meropenem for Injection Product Portfolios and Specifications
Table 88. Pfizer Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Fresenius Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 92. Fresenius Meropenem for Injection Product Portfolios and Specifications
Table 93. Fresenius Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Fresenius Main Business
Table 95. Fresenius Latest Developments
Table 96. Emcure Pharmaceuticals Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 97. Emcure Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
Table 98. Emcure Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Emcure Pharmaceuticals Main Business
Table 100. Emcure Pharmaceuticals Latest Developments
Table 101. Aurobindo Pharma Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 102. Aurobindo Pharma Meropenem for Injection Product Portfolios and Specifications
Table 103. Aurobindo Pharma Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Aurobindo Pharma Main Business
Table 105. Aurobindo Pharma Latest Developments
Table 106. Sun Pharmaceutical Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 107. Sun Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
Table 108. Sun Pharmaceutical Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Sun Pharmaceutical Main Business
Table 110. Sun Pharmaceutical Latest Developments
Table 111. Hikma Pharmaceuticals Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 112. Hikma Pharmaceuticals Meropenem for Injection Product Portfolios and Specifications
Table 113. Hikma Pharmaceuticals Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Hikma Pharmaceuticals Main Business
Table 115. Hikma Pharmaceuticals Latest Developments
Table 116. CSPC Pharmaceutical Group Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 117. CSPC Pharmaceutical Group Meropenem for Injection Product Portfolios and Specifications
Table 118. CSPC Pharmaceutical Group Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. CSPC Pharmaceutical Group Main Business
Table 120. CSPC Pharmaceutical Group Latest Developments
Table 121. Shenzhen Haibin Pharmaceutical Basic Information, Meropenem for Injection Manufacturing Base, Sales Area and Its Competitors
Table 122. Shenzhen Haibin Pharmaceutical Meropenem for Injection Product Portfolios and Specifications
Table 123. Shenzhen Haibin Pharmaceutical Meropenem for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Shenzhen Haibin Pharmaceutical Main Business
Table 125. Shenzhen Haibin Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Meropenem for Injection
Figure 2. Meropenem for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meropenem for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Meropenem for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Meropenem for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Meropenem for Injection Sales Market Share by Country/Region (2025)
Figure 10. Meropenem for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.25 g (Calculated as C??H??N?O?S)
Figure 12. Product Picture of 0.5 g (Calculated as C??H??N?O?S)
Figure 13. Product Picture of 1.0 g (Calculated as C??H??N?O?S)
Figure 14. Global Meropenem for Injection Sales Market Share by Type in 2026
Figure 15. Global Meropenem for Injection Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Severe Hospital-acquired Infections
Figure 17. Product Picture of Drug-resistant Gram-negative Infections
Figure 18. Product Picture of Others
Figure 19. Global Meropenem for Injection Sales Market Share by Clinical Indication in 2026
Figure 20. Global Meropenem for Injection Revenue Market Share by Clinical Indication (2021-2026)
Figure 21. Meropenem for Injection Consumed in Hospital
Figure 22. Global Meropenem for Injection Market: Hospital (2021-2026) & (K Units)
Figure 23. Meropenem for Injection Consumed in Clinic
Figure 24. Global Meropenem for Injection Market: Clinic (2021-2026) & (K Units)
Figure 25. Meropenem for Injection Consumed in Others
Figure 26. Global Meropenem for Injection Market: Others (2021-2026) & (K Units)
Figure 27. Global Meropenem for Injection Sale Market Share by Application (2025)
Figure 28. Global Meropenem for Injection Revenue Market Share by Application in 2026
Figure 29. Meropenem for Injection Sales by Company in 2026 (K Units)
Figure 30. Global Meropenem for Injection Sales Market Share by Company in 2026
Figure 31. Meropenem for Injection Revenue by Company in 2026 ($ millions)
Figure 32. Global Meropenem for Injection Revenue Market Share by Company in 2026
Figure 33. Global Meropenem for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Meropenem for Injection Revenue Market Share by Geographic Region in 2026
Figure 35. Americas Meropenem for Injection Sales 2021-2026 (K Units)
Figure 36. Americas Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 37. APAC Meropenem for Injection Sales 2021-2026 (K Units)
Figure 38. APAC Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 39. Europe Meropenem for Injection Sales 2021-2026 (K Units)
Figure 40. Europe Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Meropenem for Injection Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 43. Americas Meropenem for Injection Sales Market Share by Country in 2026
Figure 44. Americas Meropenem for Injection Revenue Market Share by Country (2021-2026)
Figure 45. Americas Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 46. Americas Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 47. United States Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Meropenem for Injection Sales Market Share by Region in 2026
Figure 52. APAC Meropenem for Injection Revenue Market Share by Region (2021-2026)
Figure 53. APAC Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 54. APAC Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 55. China Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. India Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Meropenem for Injection Sales Market Share by Country in 2026
Figure 63. Europe Meropenem for Injection Revenue Market Share by Country (2021-2026)
Figure 64. Europe Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 65. Europe Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 66. Germany Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. France Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Meropenem for Injection Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 74. Egypt Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Meropenem for Injection in 2026
Figure 80. Manufacturing Process Analysis of Meropenem for Injection
Figure 81. Industry Chain Structure of Meropenem for Injection
Figure 82. Channels of Distribution
Figure 83. Global Meropenem for Injection Sales Market Forecast by Region (2027-2032)
Figure 84. Global Meropenem for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Meropenem for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Meropenem for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Meropenem for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Meropenem for Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Meropenem for Injection
Figure 2. Meropenem for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meropenem for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Meropenem for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Meropenem for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Meropenem for Injection Sales Market Share by Country/Region (2025)
Figure 10. Meropenem for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.25 g (Calculated as C??H??N?O?S)
Figure 12. Product Picture of 0.5 g (Calculated as C??H??N?O?S)
Figure 13. Product Picture of 1.0 g (Calculated as C??H??N?O?S)
Figure 14. Global Meropenem for Injection Sales Market Share by Type in 2026
Figure 15. Global Meropenem for Injection Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Severe Hospital-acquired Infections
Figure 17. Product Picture of Drug-resistant Gram-negative Infections
Figure 18. Product Picture of Others
Figure 19. Global Meropenem for Injection Sales Market Share by Clinical Indication in 2026
Figure 20. Global Meropenem for Injection Revenue Market Share by Clinical Indication (2021-2026)
Figure 21. Meropenem for Injection Consumed in Hospital
Figure 22. Global Meropenem for Injection Market: Hospital (2021-2026) & (K Units)
Figure 23. Meropenem for Injection Consumed in Clinic
Figure 24. Global Meropenem for Injection Market: Clinic (2021-2026) & (K Units)
Figure 25. Meropenem for Injection Consumed in Others
Figure 26. Global Meropenem for Injection Market: Others (2021-2026) & (K Units)
Figure 27. Global Meropenem for Injection Sale Market Share by Application (2025)
Figure 28. Global Meropenem for Injection Revenue Market Share by Application in 2026
Figure 29. Meropenem for Injection Sales by Company in 2026 (K Units)
Figure 30. Global Meropenem for Injection Sales Market Share by Company in 2026
Figure 31. Meropenem for Injection Revenue by Company in 2026 ($ millions)
Figure 32. Global Meropenem for Injection Revenue Market Share by Company in 2026
Figure 33. Global Meropenem for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 34. Global Meropenem for Injection Revenue Market Share by Geographic Region in 2026
Figure 35. Americas Meropenem for Injection Sales 2021-2026 (K Units)
Figure 36. Americas Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 37. APAC Meropenem for Injection Sales 2021-2026 (K Units)
Figure 38. APAC Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 39. Europe Meropenem for Injection Sales 2021-2026 (K Units)
Figure 40. Europe Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 41. Middle East & Africa Meropenem for Injection Sales 2021-2026 (K Units)
Figure 42. Middle East & Africa Meropenem for Injection Revenue 2021-2026 ($ millions)
Figure 43. Americas Meropenem for Injection Sales Market Share by Country in 2026
Figure 44. Americas Meropenem for Injection Revenue Market Share by Country (2021-2026)
Figure 45. Americas Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 46. Americas Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 47. United States Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Canada Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Mexico Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Brazil Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. APAC Meropenem for Injection Sales Market Share by Region in 2026
Figure 52. APAC Meropenem for Injection Revenue Market Share by Region (2021-2026)
Figure 53. APAC Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 54. APAC Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 55. China Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Japan Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. South Korea Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Southeast Asia Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. India Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. Australia Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. China Taiwan Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Europe Meropenem for Injection Sales Market Share by Country in 2026
Figure 63. Europe Meropenem for Injection Revenue Market Share by Country (2021-2026)
Figure 64. Europe Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 65. Europe Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 66. Germany Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. France Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. UK Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Italy Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Russia Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Middle East & Africa Meropenem for Injection Sales Market Share by Country (2021-2026)
Figure 72. Middle East & Africa Meropenem for Injection Sales Market Share by Type (2021-2026)
Figure 73. Middle East & Africa Meropenem for Injection Sales Market Share by Application (2021-2026)
Figure 74. Egypt Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. South Africa Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 76. Israel Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 77. Turkey Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 78. GCC Countries Meropenem for Injection Revenue Growth 2021-2026 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Meropenem for Injection in 2026
Figure 80. Manufacturing Process Analysis of Meropenem for Injection
Figure 81. Industry Chain Structure of Meropenem for Injection
Figure 82. Channels of Distribution
Figure 83. Global Meropenem for Injection Sales Market Forecast by Region (2027-2032)
Figure 84. Global Meropenem for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 85. Global Meropenem for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 86. Global Meropenem for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 87. Global Meropenem for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 88. Global Meropenem for Injection Revenue Market Share Forecast by Application (2027-2032)
